Z-drug and benzodiazepine dependence: why prescribing is short term

Benzodiazepines and z-drugs act on the same calming system in the brain, boosting a natural chemical messenger called GABA. That produces rapid relief from anxiety, muscle tension and sleeplessness. With repeated use, the brain adapts by dampening its own calming signals, so the same amount does less and stopping leaves the brain overactive for a while.

The NHS says treatment with zopiclone usually lasts from a few days to a few weeks and is usually not prescribed for more than 4 weeks because tolerance develops. For diazepam, it says to use it short term, up to 4 weeks, as longer use risks dependence and withdrawal problems. Doctors aim for the lowest effective dose for the shortest time to minimise the risk.

Dependence does not require high doses or unusual behaviour. A common story is a short course for a crisis, such as bereavement, a stressful period or a bout of insomnia, that is repeated and then becomes a nightly habit. After some weeks, sleep without the tablet becomes difficult, partly because of withdrawal-type symptoms between doses, which makes the person and prescriber feel it is still needed.

Signs include taking it every night to sleep at all, anxiety as the next dose approaches, needing more over time, running out early, and finding that the tablet no longer helps but stopping feels impossible. Dependence of this kind is physical as well as psychological, and it is not a character failing.

• Needing the tablet to feel normal rather than for a specific problem.

• Rising doses or extra tablets "just in case".

• Rebound anxiety or insomnia on missed doses.

• Feeling flat, forgetful or slowed during the day.

The NHS says stopping zopiclone suddenly can cause withdrawal symptoms such as feeling agitated or anxious, and that stopping diazepam abruptly can cause headaches, muscle pain and heightened anxiety. Other recognised effects include sleep disturbance, sweating, tremor, palpitations, sensitivity to light and sound, low mood and, after heavy or long use, seizures.

Because seizures can occur, abrupt cessation after long-term use is unsafe and a gradual plan is advised. Our guide on benzodiazepine withdrawal seizures covers that complication in more detail, while the broader pages on benzodiazepine dependence describe the clinical picture.

The NHS says your doctor will reduce the dose gradually. A typical approach is to agree a plan with small steps, held for a period long enough to settle, and sometimes switching to a longer-acting benzodiazepine to smooth the process. The pace is flexible: if symptoms become unmanageable, the plan can pause rather than reverse. Planning avoids cold turkey stopping, which is the most dangerous approach.

Non-drug approaches help in parallel. For insomnia, cognitive behavioural therapy for insomnia and good sleep habits are recommended first-line treatments and are more effective long term than tablets. For anxiety, talking therapies and self-help programmes support the process. A local drug and alcohol service can help if use has become hard to control.

• Agree timing, step size and review dates in writing.

• Keep a sleep and symptom diary.

• Limit alcohol and caffeine and keep regular waking times.

• Ask about CBT for insomnia or anxiety support alongside.

Next-day drowsiness is common. The NHS says not to drive, ride a bike or use machinery for 12 hours after zopiclone if drowsy or less alert, and not to drive, cycle or use tools until you feel better on diazepam. Older people face extra risk of falls and confusion. Alcohol intensifies the effects, and the NHS says to avoid it with both medicines and to avoid grapefruit juice with diazepam.

Serious but rare effects of zopiclone include difficulty breathing, sleepwalking, allergic reactions and mental health effects such as hallucinations or suicidal thoughts. The NHS says not to co-sleep with infants after taking it, and it is unsuitable in people with breathing problems, liver problems, muscle weakness, sleep apnoea or a past addiction to alcohol or drugs. Combined with opioids or gabapentinoids, the risk of breathing depression rises.

The MHRA's Drug Safety Update index records an item published on 8 January 2026 on improving the information supplied with gabapentinoids, benzodiazepines and z-drugs, which reviewed warnings about addiction, dependence, withdrawal and tolerance. We have seen only the listing, so refer to the update itself for details. Z-drugs and benzodiazepines are controlled drugs, which affects how they are prescribed and supplied.

Ask the GP for a review if you have used either type for more than a few weeks, or if you are worried about dependence. Call NHS 111 for overdose or serious side effects, and 999 for breathing difficulty, collapse, or if someone cannot be woken. Seizures, severe confusion or suicidal thoughts during withdrawal also need emergency care.